Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

Interstitial Lung Disease Drug Development Summit

Evvnt Promotion / evvnt
-
27.04.2021 - 29.04.2021  Online
Time: 09:00 - 15:00
 
Temi della conferenza
With the entire world's attention focused firmly on pulmonary fibrosis in the wake of COVID19 and the landmark INBUILD study dramatically overhauling the ILD drug development landscape, biopharma are finally on the cusp of developing and disseminating life-changing therapeutics for patients suffering with interstitial lung disease.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Ahmad Nabhan, Postdoctoral Scholar, Genentech, Christina Wenglen, Head of Research, AnaMar, Craig Conoscenti, Medical Expert ILD Respiratory Clinical Development and Medical Affairs, Boehringer Ingelheim and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/729096-2?pid=4832
Mr. Customer Service
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference + Workshops Day - Industry: $2799.0, Conference Only - Industry: $1999.0, Workshop Day - Industry: $899.0, Conference + Workshops Day - Academic: $1899.0, Conference Only - Academic: $1299.0, Workshops Day - Academic: $699.0
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Hilfswerk AustriaSwiss Tropical and Public Health InstituteEuropean Health Forum GasteinÄrzte der WeltOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Akademie der ÄrzteCharité International AcademyÄrztekammer für Wien